eGenesis
Share
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.
04/04/2022
We’re excited to welcome Eliezer Katz, M.D., FACS, our new Chief Medical Officer who has nearly 20 years of experience as a surgeon and has become a leader in clinical development of therapeutics in transplant in the pharmaceutical industry.
See: https://bit.ly/3u4YZfi
01/31/2022
Michael Curtis, our President of R&D, explains to Science News why eGenesis, Inc. is focused first on human-compatible kidney transplant. 83 percent of the transplant waiting list are people who need kidneys.
Read here: https://bit.ly/3GjhorA
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
Cambridge, MA
02139
